Supabase reached $5 billion value by rejecting $1 million worth of contracts. This is why.

Biometric programming has revolutionized the technology industry, and not only that Loved ones and Repeats Of the world that wins. Startups that build the infrastructure behind them also benefit.

Supabase, the open source database platform that has become the backend of choice for the bioprogramming world, It raised $100 million at a valuation of $5 billion Just months after closing $200 million at $2 billion. But co-founder and CEO Paul Copleston has a surprising strategy: He keeps turning down million-dollar institutional contracts from wealthy but demanding clients. He’s betting instead that if he sticks to his vision for the product, the world will come to him. So far, he was right.

Today on TechCrunch’s Equity podcast, Julie Port sat down with Copplestone to explore the rise of Supabase and what it means for the critical programming, developers, and database giants that have historically dominated this market.

Subscribe to shares on Apple Podcast, Overcast, Spotify And all the actors. You can also follow stocks on X and TopicsatEquityPod.